Xconomy

FEBRUARY 17, 2017

The consternation about President Donald Trump’s coming pick for FDA commissioner was palpable this week at the BIO CEO & Investor Conference in New York.

Pricing 61

Pricing Conference News Ideas 61

Xconomy

OCTOBER 28, 2016

—As the North American Cystic Fibrosis Conference kicked off in Orlando, FL, Vertex Pharmaceuticals (NASDAQ: VRTX ) said a key part of its plan to defend its industry-leading cystic fibrosis franchise is moving forward. THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases.

Pricing 40

Pricing Conference News Study 40

Xconomy

APRIL 12, 2019

A major conference devoted to liver disease kicked off with updates from the race for approval of the world’s first drug to treat a form of advanced liver disease called nonalcoholic steatohepatitis, or NASH. It’s been a busy week, and the biggest biopharma news of the week could happen after you read this.

Pricing 63

Pricing Conference News San Diego 63

Xconomy

JANUARY 2, 2018

Next week, a big slice of the biomedical industry is gathering in San Francisco for the annual J.P. Morgan Healthcare Conference and other life sciences events that have emerged like sprouts around the base of an old redwood tree. Since then, Trump hasn’t exactly put more cops on the pharma-homicide beat. Is 2018 the year.

Pricing 64

Pricing Conference Funding San Diego 64

Xconomy

APRIL 6, 2018

The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms. There were plenty of policy and drug-price headlines, Read more » Reprints | Share:

Study 55

Study Pricing Conference Marketing 55

Xconomy

JANUARY 11, 2017

On the campaign trail and as president-elect he has made occasional noises about drug pricing—giving the U.S. Medicare system, the largest buyer of drugs in the world, the right to negotiate prices, for instance. This morning, in his first press conference, Trump went further. Here’s the transcript, courtesy of NPR.

Company 40

Company Companies Pricing Press 40

Xconomy

OCTOBER 7, 2016

The firm will now focus on its miniLab, which CEO Elizabeth Holmes touted as a follow-on version of its Edison test system at a scientific conference in August. PRICE FIGHTS. With some caveats, ICER recommended lower prices. She refused to discuss Edison at the time. for their work on molecular machines.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

JUNE 6, 2017

The American Society of Clinical Oncology conference is wrapping up, and the closely-watched medical meeting-slash-hype machine produced its usual array of data. [ Note: Ben Fidler coauthored this report.] Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Conference 59

Conference News Pricing Report 59

Xconomy

MAY 24, 2018

In the heart of California’s wine country, it is our most exclusive, intimate, and unique conference. We have special prices for those at startups and non-profit or government organizations—so ask us about those as.

Conference 45

Conference Pricing Organization Sites 45

Xconomy

AUGUST 30, 2019

But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. You might be camping, barbecuing, or sleeping on Monday. It’s Labor Day, after all. Inclisiran’s owner, the Medicines Co.,

Slides 80

Slides Conference Venture Capital San Diego 80

Xconomy

JANUARY 13, 2017

This past week, the biopharma industry made its annual January pilgrimage to San Francisco for the J.P. Morgan Healthcare Conference. Pricing, Trump, PCSK9 Battle, and Diversity. Earlier today, Alex Lash and I offered a few tidbits from our notebooks —more to come later.

Conference 40

Conference Pricing San Diego Company 40

Xconomy

SEPTEMBER 2, 2016

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson. .

News 57

News San Diego Journal Technical Review 57

Xconomy

APRIL 9, 2018

As readers know, we strive to cover a wide range of innovation sectors, from tech and life sciences to healthcare and education—all with a mix of on-the-ground reporting, daily news stories, in-depth features and analysis, and events and conferences.

News 86

News Education Conference Report 86

Xconomy

JUNE 3, 2016

This weekend, much of academia and industry involved in cancer will gather in Chicago for the annual American Society of Clinical Oncology conference. Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. billion acquisition of San Diego’s Auspex Pharmaceuticals last year.

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

DECEMBER 9, 2016

President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress.

News 40

News Patents Conference Pricing 40

Xconomy

JUNE 10, 2016

—At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves. The new prices don’t reflect rebates and discounts. Ed Silverman at STAT reported the analyst note first.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

Xconomy

JULY 21, 2016

After a year in which Biogen’s share price has fallen by more than a third and one of its top drug prospects failed, Scangos, who has led the company since 2010, has announced plans to step down. Biogen is holding a conference call this morning to discuss its quarterly earnings. [ Updated, 9:20 a.m. Reprints | Share:

San Diego 40

San Diego Conference Pricing Acquisition 40

Xconomy

AUGUST 5, 2016

Just as many M&A rumors flame out as lead to deals, of course, but the news was enough to give Biogen’s stock price a big bump, and ignite chatter about what a sale of one of biotech’s heavyweights would mean, particularly for the Boston area. The rumors boosted Biogen’s sinking stock price nearly 10 percent.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

OCTOBER 21, 2016

The staff also crowed over Clinton’s tweet—a reaction last summer to the first revelations about Martin Shkreli’s price gouging —that sent biopharma stocks downhill. The hikes were first reported earlier this month by Adam Feuerstein of The Street. .

Research 40

Research San Diego Report Slides 40

Xconomy

JANUARY 11, 2019

Diabetes drugs are Eli Lilly’s bread and butter, but the pharmaceutical giant hasn’t lost its appetite for cancer drugs. It grabbed hold of a few more this week by betting $8 billion on Loxo Oncology.

San Diego 76

San Diego Company Companies Conference 76

SoCal Delicious

OCTOBER 8, 2012

Developments Blog. Prices are soaring in the beachfront communities tech types favor, and rents in these. Prices have gone up dramatically on this beachfront strip. Venices median home price in the first eight months of 2012 broke the $1 million barrier, rising to $1,012,000 from $899,000 in the first eight months of 2011.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44